Intervention library
What helps. What might. What has not earned your attention yet.
Nara reads the difficult science, separates usefulness from novelty, and gives you the conclusion first. The full evidence is still here when you want it.
MethodologyFive questions, never one scoreOpen the framework only when you want to see how Nara separates the evidence.
- Evidence maturity
- How far the research has actually progressed for a specific claim.
- Evidence directness
- Whether the evidence is in dogs, in another species, or mechanistic only.
- Safety certainty
- How well the risk profile is characterized — separately from efficacy.
- Personalized relevance
- Whether it applies to this dog, right now, given the profile we hold.
- Actionability
- Who should be making the decision, and in what setting.
- Review depth
- Full reviews carry claim-level evidence. Briefings give a bounded position. Watchlist entries stay deliberately light until the review is complete.
For your dog
Loading your dog’s context…
Foundations
The boring interventions may still matter most. These have the strongest and most direct canine support, and they are owner-directed.
Foundations
Healthy body condition
Keeping a dog lean across life is the single best-supported lever an owner directly controls.
Evidence assessed · 2026-08-12
Foundations
Nutrition
Diet completeness, calorie accuracy, and feeding pattern — the substrate everything else sits on.
Evidence assessed · 2026-08-12
Foundations
Protein adequacy
Whether an ageing dog is getting enough high-quality protein to defend lean mass.
Evidence assessed · 2026-08-12
Foundations
Exercise
Volume, intensity, and variety of loading across a dog's week.
Evidence assessed · 2026-08-12
Foundations
Muscle preservation
Defending lean mass through mid and late life, rather than reacting to visible loss.
Evidence assessed · 2026-08-12
Foundations
Dental health
Periodontal disease is the most common diagnosis in adult dogs, it is painful, and it is largely preventable at home.
Evidence assessed · 2026-08-12
Foundations
Preventive care
Screening cadence, early detection, and baseline diagnostics before decline is visible.
Evidence assessed · 2026-08-12
Foundations
Vaccination and parasite prevention
Risk-appropriate protection against preventable disease burden.
Evidence assessed · 2026-08-12
Optimization
Reasonable additions once the foundations are in place, usually for a defined purpose rather than for everything.
Optimization
Omega-3 EPA and DHA
The best-studied supplement in dogs, with real canine trial data for a defined indication rather than for longevity.
Evidence assessed · 2026-08-12
Optimization
Creatine
Cellular energy buffering and muscle performance, largely untested in dogs.
Evidence assessed · 2026-08-12
Optimization
Taurine
Essential in cats, conditionally relevant in some canine diets and breeds.
Evidence assessed · 2026-08-12
Optimization
Joint-support interventions
Glucosamine, chondroitin, green-lipped mussel, and related products.
Evidence assessed · 2026-08-12
Optimization
Cognitive enrichment
Scent work, problem solving, and novelty as cognitive load.
Evidence assessed · 2026-08-12
Optimization
Sleep and recovery
Sleep quality, fragmentation, and recovery between loading days.
Evidence assessed · 2026-08-12
Optimization
Biomarker tracking
Baseline and trend bloodwork as an early-detection tool.
Evidence assessed · 2026-08-12
Emerging
Early evidence is not proof. It is not nothing, either. These are worth understanding and, in some cases, worth following closely.
Emerging
Astaxanthin
A carotenoid antioxidant with limited canine outcome data.
Evidence assessed · 2026-08-12
Emerging
Urolithin A
A gut-derived postbiotic studied for mitophagy and muscle function.
Evidence assessed · 2026-08-12
Emerging
Ergothioneine
A dietary thiol with cytoprotective mechanisms under study.
Evidence assessed · 2026-08-12
Emerging
Akkermansia
A single-strain probiotic tied to metabolic signalling in rodents.
Evidence assessed · 2026-08-12
Emerging
NAD+ precursors
NMN and NR, studied for declining NAD+ availability with age.
Evidence assessed · 2026-08-12
Experimental and investigational
Scientifically serious, not ready for routine owner-directed use. Listed here so you can understand them — not because Nara recommends them.
Experimental and investigational
Senolytics
Clearing senescent cells — a strong mechanism with thin canine data.
Evidence assessed · 2026-08-12
Experimental and investigational
Rapamycin
The most scientifically important experimental canine longevity intervention, and still a medication-level decision.
Evidence assessed · 2026-08-12
Experimental and investigational
LOY-001
An investigational large-breed longevity candidate targeting IGF-1 signalling.
Evidence assessed · 2026-08-12
Experimental and investigational
LOY-002
An investigational senior-dog longevity candidate.
Evidence assessed · 2026-08-12
Experimental and investigational
BPC-157
A synthetic peptide widely promoted online with very thin canine data.
Evidence assessed · 2026-08-12
Experimental and investigational
TB-500
A thymosin beta-4 fragment marketed for tissue repair.
Evidence assessed · 2026-08-12
Experimental and investigational
MOTS-c
A mitochondrial-derived peptide studied for metabolic signalling.
Evidence assessed · 2026-08-12
Experimental and investigational
Thymosin alpha-1
An immunomodulatory peptide with limited canine data.
Evidence assessed · 2026-08-12
Experimental and investigational
Epitalon
A synthetic peptide promoted for telomere effects on very thin evidence.
Evidence assessed · 2026-08-12
Experimental and investigational
Stem-cell therapies
Cell-based approaches, mostly studied for specific orthopaedic indications.
Evidence assessed · 2026-08-12
Experimental and investigational
Gene therapies
Early-stage genetic approaches to age-related decline.
Evidence assessed · 2026-08-12
Priority before novelty
Interesting is not the same as important.
Nara keeps every serious intervention visible, then compares it with the higher-confidence opportunities already present in your dog’s plan.
Build my dog’s plan